Trials / Completed
CompletedNCT06115681
Real-world Study of Dedifferentiated Liposarcoma Patients in China
Demographic, Clinical Characteristics, and Treatment Outcomes Associated With Dedifferentiated Liposarcoma Patients in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,390 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will characterize patients with dedifferentiated liposarcoma (DDLPS) in China, including an understanding of demographic, and clinical characteristics as well as treatment patterns and clinical outcomes associated with the current real-world treatment.
Conditions
Timeline
- Start date
- 2024-03-13
- Primary completion
- 2024-05-15
- Completion
- 2024-05-15
- First posted
- 2023-11-03
- Last updated
- 2025-07-10
- Results posted
- 2025-07-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06115681. Inclusion in this directory is not an endorsement.